• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用 QTAIM 计算和氢键动态倾向分析理论模型预测 Sphingosine Kinase 1 配体的抑制作用。

Theoretical models to predict the inhibitory effect of ligands of sphingosine kinase 1 using QTAIM calculations and hydrogen bond dynamic propensity analysis.

机构信息

Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco, 915, 5700, San Luis, Argentina.

IMIBIO-CONICET, UNSL, Chacabuco 915, 5700, San Luis, Argentina.

出版信息

J Comput Aided Mol Des. 2018 Jul;32(7):781-791. doi: 10.1007/s10822-018-0129-7. Epub 2018 Jul 3.

DOI:10.1007/s10822-018-0129-7
PMID:29971548
Abstract

We report here the results of two theoretical models to predict the inhibitory effect of inhibitors of sphingosine kinase 1 that stand on different computational basis. The active site of SphK1 is a complex system and the ligands under the study possess a significant conformational flexibility; therefore for our study we performed extended simulations and proper clusterization process. The two theoretical approaches used here, hydrogen bond dynamics propensity analysis and Quantum Theory of Atoms in Molecules (QTAIM) calculations, exhibit excellent correlations with the experimental data. In the case of the hydrogen bond dynamics propensity analysis, it is remarkable that a rather simple methodology with low computational requirements yields results in excellent accord with experimental data. In turn QTAIM calculations are much more computational demanding and are also more complex and tedious for data analysis than the hydrogen bond dynamic propensity analysis. However, this greater computational effort is justified because the QTAIM study, in addition to giving an excellent correlation with the experimental data, also gives us valuable information about which parts or functional groups of the different ligands are those that should be replaced in order to improve the interactions and thereby to increase the affinity for SphK1. Our results indicate that both approaches can be very useful in order to predict the inhibiting effect of new compounds before they are synthesized.

摘要

我们在此报告了两种理论模型的结果,这些模型用于预测不同计算基础上的 SphK1 抑制剂的抑制效果。SphK1 的活性部位是一个复杂的系统,研究中的配体具有显著的构象灵活性;因此,我们对研究进行了扩展模拟和适当的聚类处理。这里使用的两种理论方法,氢键动力学倾向分析和分子中的原子量子理论 (QTAIM) 计算,与实验数据具有极好的相关性。在氢键动力学倾向分析的情况下,值得注意的是,一种相对简单的方法,具有较低的计算要求,产生的结果与实验数据非常吻合。反过来,QTAIM 计算的计算要求更高,并且数据分析比氢键动态倾向分析更复杂和繁琐。然而,这种更大的计算工作量是合理的,因为 QTAIM 研究除了与实验数据具有极好的相关性外,还为我们提供了有关哪些部分或不同配体的功能基团应该被替换的有价值的信息,以便改善相互作用,从而提高对 SphK1 的亲和力。我们的结果表明,这两种方法都可以非常有用,可以在新化合物合成之前预测它们的抑制效果。

相似文献

1
Theoretical models to predict the inhibitory effect of ligands of sphingosine kinase 1 using QTAIM calculations and hydrogen bond dynamic propensity analysis.运用 QTAIM 计算和氢键动态倾向分析理论模型预测 Sphingosine Kinase 1 配体的抑制作用。
J Comput Aided Mol Des. 2018 Jul;32(7):781-791. doi: 10.1007/s10822-018-0129-7. Epub 2018 Jul 3.
2
Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations.联合 MD/QTAIM 技术评估配体-受体相互作用。范围和局限性。
Eur J Med Chem. 2020 Dec 15;208:112792. doi: 10.1016/j.ejmech.2020.112792. Epub 2020 Sep 6.
3
An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors.一项旨在鉴定鞘氨醇激酶1抑制剂新型骨架的综合研究。
Eur J Med Chem. 2017 Oct 20;139:461-481. doi: 10.1016/j.ejmech.2017.08.017. Epub 2017 Aug 10.
4
In Silico Identification of Novel Orthosteric Inhibitors of Sphingosine Kinase 1 (SK1).鞘氨醇激酶1(SK1)新型正构抑制剂的计算机模拟鉴定
Curr Protein Pept Sci. 2018;19(5):430-444. doi: 10.2174/1389203718666161108092842.
5
Second generation of pyrimidin-quinolone hybrids obtained from virtual screening acting as sphingosine kinase 1 inhibitors and potential anticancer agents.从虚拟筛选中获得的第二代嘧啶-喹诺酮杂合体,作为鞘氨醇激酶 1 抑制剂和潜在的抗癌药物。
Bioorg Chem. 2024 Mar;144:107112. doi: 10.1016/j.bioorg.2024.107112. Epub 2024 Jan 17.
6
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.评估鞣花酸作为鞘氨醇激酶 1 的抑制剂:一种针对癌症治疗的靶向方法。
Biomed Pharmacother. 2019 Oct;118:109245. doi: 10.1016/j.biopha.2019.109245. Epub 2019 Jul 25.
7
Performance of the MM/GBSA scoring using a binding site hydrogen bond network-based frame selection: the protein kinase case.基于结合位点氢键网络的框架选择进行MM/GBSA评分的性能:蛋白激酶实例
Phys Chem Chem Phys. 2014 Jul 21;16(27):14047-58. doi: 10.1039/c4cp01378f. Epub 2014 Jun 5.
8
Evaluating the conformational space of the active site of D dopamine receptor. Scope and limitations of the standard docking methods.评估 D 多巴胺受体活性位点的构象空间。标准对接方法的范围和局限性。
J Comput Chem. 2022 Jul 15;43(19):1298-1312. doi: 10.1002/jcc.26938. Epub 2022 May 31.
9
An overview about the impact of hinge region towards the anticancer binding affinity of the Ck2 ligands: a quantum chemical analysis.铰链区对 CK2 配体抗癌结合亲和力影响的概述:量子化学分析。
J Biomol Struct Dyn. 2019 Sep;37(15):3859-3876. doi: 10.1080/07391102.2018.1533498. Epub 2018 Dec 5.
10
Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors.基于结构的药物设计研究,旨在发现新型查尔酮衍生物作为潜在的表皮生长因子受体 (EGFR) 抑制剂。
Molecules. 2018 Dec 5;23(12):3203. doi: 10.3390/molecules23123203.

引用本文的文献

1
Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp.作为 P-糖蛋白介导的多药耐药性的逆转剂,喹啉酮-嘧啶类混合物的构效关系和结合模式。
Sci Rep. 2021 Aug 19;11(1):16856. doi: 10.1038/s41598-021-96226-6.
2
Design of new quinolin-2-one-pyrimidine hybrids as sphingosine kinases inhibitors.设计新型喹啉-2(1H)-酮-嘧啶类化合物作为鞘氨醇激酶抑制剂。
Bioorg Chem. 2020 Jan;94:103414. doi: 10.1016/j.bioorg.2019.103414. Epub 2019 Nov 13.

本文引用的文献

1
Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of Hieronymiella species.从 Hieronymiella 属鳞茎中生物碱的胆碱酯酶抑制作用及计算机分析。
Phytomedicine. 2018 Jan 15;39:66-74. doi: 10.1016/j.phymed.2017.12.020. Epub 2017 Dec 20.
2
New substituted aminopyrimidine derivatives as BACE1 inhibitors: in silico design, synthesis and biological assays.新型取代氨基嘧啶衍生物作为 BACE1 抑制剂:计算机辅助设计、合成与生物活性评价。
J Biomol Struct Dyn. 2019 Jan;37(1):229-246. doi: 10.1080/07391102.2018.1424036. Epub 2018 Feb 1.
3
An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors.
一项旨在鉴定鞘氨醇激酶1抑制剂新型骨架的综合研究。
Eur J Med Chem. 2017 Oct 20;139:461-481. doi: 10.1016/j.ejmech.2017.08.017. Epub 2017 Aug 10.
4
Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes.源自两栖动物皮肤的新型肽的分子设计与合成,其作为胆碱酯酶抑制剂发挥作用。
J Pept Sci. 2017 Mar;23(3):236-244. doi: 10.1002/psc.2974. Epub 2017 Feb 2.
5
Hydrogen Bond Dynamic Propensity Studies for Protein Binding and Drug Design.用于蛋白质结合和药物设计的氢键动力学倾向研究
PLoS One. 2016 Oct 28;11(10):e0165767. doi: 10.1371/journal.pone.0165767. eCollection 2016.
6
Dopaminergic isoquinolines with hexahydrocyclopenta[ij]-isoquinolines as D2-like selective ligands.具有六氢环戊并[ij]异喹啉作为 D2 样选择性配体的多巴胺能异喹啉。
Eur J Med Chem. 2016 Oct 21;122:27-42. doi: 10.1016/j.ejmech.2016.06.009. Epub 2016 Jun 10.
7
New small-size peptides modulators of the exosite of BACE1 obtained from a structure-based design.基于结构设计获得的 BACE1 外位点新型小肽调节剂。
J Biomol Struct Dyn. 2017 Feb;35(2):413-426. doi: 10.1080/07391102.2016.1145143. Epub 2016 Mar 8.
8
"Chameleonic" backbone hydrogen bonds in protein binding and as drug targets.蛋白质结合及作为药物靶点中的“变色龙式”主链氢键
Eur Phys J E Soft Matter. 2015 Oct;38(10):107. doi: 10.1140/epje/i2015-15107-3. Epub 2015 Oct 19.
9
Crystal Structure of Sphingosine Kinase 1 with PF-543.鞘氨醇激酶1与PF-543的晶体结构
ACS Med Chem Lett. 2014 Oct 27;5(12):1329-33. doi: 10.1021/ml5004074. eCollection 2014 Dec 11.
10
2,3,9- and 2,3,11-trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands.2,3,9- 和 2,3,11-三取代的四氢异喹啉类作为 D2 多巴胺能配体。
Eur J Med Chem. 2013 Oct;68:150-66. doi: 10.1016/j.ejmech.2013.07.036. Epub 2013 Aug 11.